Masato Kataoka

619 total citations
51 papers, 411 citations indexed

About

Masato Kataoka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Masato Kataoka has authored 51 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Masato Kataoka's work include Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (12 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Masato Kataoka is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (12 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Masato Kataoka collaborates with scholars based in Japan, Greece and Tunisia. Masato Kataoka's co-authors include Satoshi Morita, Yoshinori Munemoto, Naoki Nagata, Junichi Sakamoto, Toru Aoyama, Hideyuki Mishima, Chu Matsuda, Tadashi Watanabe, Toru Kono and Masahiro Takeuchi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgical Oncology and BMC Cancer.

In The Last Decade

Masato Kataoka

42 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masato Kataoka Japan 12 200 193 136 68 58 51 411
Toshimoto Kimura Japan 14 144 0.7× 190 1.0× 269 2.0× 64 0.9× 29 0.5× 49 454
Huihong Jiang China 12 86 0.4× 200 1.0× 124 0.9× 72 1.1× 26 0.4× 26 391
E Piana Italy 11 340 1.7× 390 2.0× 109 0.8× 67 1.0× 65 1.1× 28 592
Yuming Rong China 13 105 0.5× 178 0.9× 81 0.6× 86 1.3× 11 0.2× 43 350
Fatih Köse Türkiye 13 161 0.8× 148 0.8× 143 1.1× 35 0.5× 12 0.2× 65 520
Kenkichi Hashimoto Japan 10 107 0.5× 241 1.2× 272 2.0× 53 0.8× 23 0.4× 34 514
Marie‐Line Garcia‐Larnicol France 10 245 1.2× 298 1.5× 210 1.5× 25 0.4× 89 1.5× 24 520
Noriaki Tokumoto Japan 13 191 1.0× 130 0.7× 196 1.4× 135 2.0× 97 1.7× 35 468
Süleyman Alıcı Türkiye 12 136 0.7× 258 1.3× 142 1.0× 77 1.1× 13 0.2× 40 540
Masafumi Nomura Japan 10 220 1.1× 180 0.9× 172 1.3× 29 0.4× 71 1.2× 24 545

Countries citing papers authored by Masato Kataoka

Since Specialization
Citations

This map shows the geographic impact of Masato Kataoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Kataoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Kataoka more than expected).

Fields of papers citing papers by Masato Kataoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Kataoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Kataoka. The network helps show where Masato Kataoka may publish in the future.

Co-authorship network of co-authors of Masato Kataoka

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Kataoka. A scholar is included among the top collaborators of Masato Kataoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Kataoka. Masato Kataoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakai, Daisuke, Shigenori Kadowaki, Ryohei Kawabata, et al.. (2025). Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial. Journal of Clinical Oncology. 43(19). 2196–2207. 3 indexed citations
2.
Hu, Qingjiang, Eiji Oki, Teppei Yamada, et al.. (2023). Genomic characterization between HER2‐positive and negative gastric cancer patients in a prospective trial. Cancer Medicine. 12(15). 16649–16660. 7 indexed citations
3.
Suenaga, Masaya, et al.. (2022). Small Bowel Obstruction due to Meckel’s Diverticulum Containing True Enteroliths Treated by Laparoscopic Surgery. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 47(2). 116–123.
5.
Sugiyama, Keiji, et al.. (2021). The impact of nutrition support in advanced gastric adenocarcinoma patients treated with chemotherapy.. Journal of Clinical Oncology. 39(3_suppl). 208–208. 1 indexed citations
6.
Kakeji, Yoshihiro, Kazuhiro Yoshida, Yasuhiro Kodera, et al.. (2021). Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07. Gastric Cancer. 25(1). 188–196. 51 indexed citations
7.
Tanioka, Hiroaki, Michitaka Honda, Chihiro Tanaka, et al.. (2019). Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety. International Journal of Clinical Oncology. 24(7). 836–841. 3 indexed citations
9.
10.
Tanaka, Haruyoshi, Kazuya Hasegawa, Nao Takano, et al.. (2016). A resected case of symptomatic acinar cell cystadenoma of the pancreas displacing the main pancreatic duct. Surgical Case Reports. 2(1). 39–39. 11 indexed citations
11.
Kataoka, Masato, et al.. (2013). A Case of Appendiceal Mucinous Cystadenoma in Persistent Appendices. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(11). 3073–3076. 1 indexed citations
12.
Nakayama, Hiroshi, et al.. (2013). Two Cases of Hemosuccus Pancreaticus due to Chronic Pancreatitis. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(9). 2587–2592.
13.
Kato, Aya, et al.. (2006). Minimally Invasive Surgery Using Laparoscopy for Intestinal Adhesion. 26(1). 31–36.
14.
Moritani, Suzuko, Shu Ichihara, Yukio Seki, Masato Kataoka, & Toyoharu Yokoi. (2006). Pulmonary capillary hemangiomatosis incidentally detected in a lobectomy specimen for a metastatic colon cancer. Pathology International. 56(6). 350–357. 15 indexed citations
15.
Yamamoto, Hidekazu, Akira Tanaka, Hideyuki Yoshida, et al.. (2000). A Case of Biliary Cystadenocarcinoma.. The Japanese Journal of Gastroenterological Surgery. 33(2). 215–219. 2 indexed citations
16.
Tanaka, Akira, Hidekazu Yamamoto, Ryuji Okamura, et al.. (2000). Extrahepatic large hepatocellular carcinoma with peritoneal dissemination: multimodal treatment, including four surgical operations. Journal of Hepato-Biliary-Pancreatic Surgery. 7(3). 339–344. 8 indexed citations
17.
Kondo, Ken, Yasuhisa Yokoyama, Isao Yokoyama, et al.. (1996). Malignant lymphoma of the gastric stump developing 25 years after a distal gastrectomy for benign gastric disease: Report of a case. Surgery Today. 26(10). 803–806. 2 indexed citations
18.
Ichihara, T, et al.. (1995). Laparoscopic Cholecystectomy as Total Biopsy for Elevated Lesion of Gallbladder.. The Japanese Journal of Gastroenterological Surgery. 28(5). 1043–1048. 1 indexed citations
19.
Kawasaki, Shingo, Masato Kataoka, Masaji Yamauchi, et al.. (1992). Polyoxyethylene‐modified Superoxide Dismutase Reduces Side Effects of Adriamycin and Mitomycin C. Japanese Journal of Cancer Research. 83(8). 899–906. 7 indexed citations
20.
Hamaguchi, Michinari, Tadashi Watanabe, Seiji Akiyama, et al.. (1991). Aberrant Elevation of Tyrosine‐specific Phosphorylation in Human Gastric Cancer Cells. Japanese Journal of Cancer Research. 82(12). 1428–1435. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026